Skip to content

Clinical trials

Completed Phase 3 Hypercholesterolemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Status: Completed Clear all

222 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
200214
200316
200415
200523
200611
200715
20087
20093
20102
20114
201212
201318
20146
20158
201613
20176
20183
20193
20205
20216
20226
20236
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed222

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Organon and Co55
AstraZeneca22
Amgen21
Sanofi18
Merck Sharp & Dohme LLC9
Takeda8
Kowa Research Europe7
Esperion Therapeutics, Inc.6
Kastle Therapeutics, LLC5
National Heart, Lung, and Blood Institute (NHLBI)5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia222
Hyperlipidemias37
Dyslipidemias35
Atherosclerosis21
Coronary Disease20
Hyperlipoproteinemia Type II20
Hypertension15
Cardiovascular Diseases11
Diabetes Mellitus10
Homozygous Familial Hypercholesterolemia6

Trials

Showing 1 to 25 of 222. Each trial links to its page on Pharma Observatory.

122 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.